Gelteq Limited Ordinary Shares (GELS) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.0M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.08 to the broader market. Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. Led by Nathan Jacob Givoni, public since 2024-10-29.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for GELS as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →